Table 1. The hrHPV prevalences in 10-year age-groups, for all women combined (n=45 362) and for women with normal cytology (n=43 737).
Age-group | n | Total hrHPV (%) | HPV16 | HPV18 | HPV31 | HPV33 | HPV35 | HPV39 | HPV45 | HPV51 | HPV52 | HPV56 | HPV58 | HPV59 | HPV66 | HPV68 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
All women | ||||||||||||||||
18–24 | 482 | 102 (21.2) | 36 | 11 | 15 | 6 | 4 | 6 | 3 | 13 | 8 | 14 | 4 | 5 | 14 | 0 |
25–34 | 10 828 | 1161 (10.7) | 419 | 127 | 174 | 76 | 48 | 67 | 78 | 93 | 93 | 79 | 65 | 26 | 76 | 17 |
35–44 | 15 303 | 753 (4.9) | 235 | 60 | 112 | 48 | 39 | 39 | 65 | 46 | 36 | 52 | 53 | 14 | 30 | 15 |
45–54 | 11 556 | 321 (2.8) | 80 | 37 | 36 | 18 | 12 | 8 | 22 | 21 | 19 | 34 | 16 | 8 | 24 | 1 |
55–65 | 7193 | 184 (2.6) | 49 | 14 | 23 | 14 | 10 | 6 | 6 | 15 | 7 | 20 | 11 | 5 | 10 | 4 |
Total | 45 362 | 2521 (5.6) | 819 | 249 | 360 | 162 | 113 | 126 | 174 | 188 | 163 | 199 | 149 | 58 | 154 | 37 |
Women with normal cytology | ||||||||||||||||
18–24 | 440 | 80 (18.2) | 31 | 6 | 11 | 4 | 4 | 5 | 3 | 9 | 5 | 11 | 2 | 4 | 9 | 0 |
25–34 | 10 238 | 770 (7.5) | 246 | 81 | 127 | 38 | 31 | 44 | 50 | 62 | 55 | 53 | 41 | 18 | 60 | 9 |
35–44 | 14 751 | 508 (3.4) | 132 | 39 | 76 | 31 | 29 | 25 | 48 | 26 | 23 | 39 | 35 | 13 | 19 | 11 |
45–54 | 11 239 | 244 (2.2) | 52 | 26 | 26 | 13 | 7 | 5 | 19 | 10 | 17 | 30 | 11 | 8 | 19 | 1 |
55–65 | 7069 | 156 (2.2) | 41 | 11 | 19 | 11 | 10 | 6 | 6 | 9 | 5 | 20 | 10 | 5 | 10 | 4 |
Total | 43 737 | 1758 (4.0) | 502 | 163 | 259 | 97 | 81 | 85 | 126 | 116 | 105 | 153 | 99 | 48 | 117 | 25 |
In each age group, the number of women that is infected with each of the 14 HPV types is shown.